Evidence map›Paper›PMID 33996361›Full record

ArticleIntractable & rare diseases research2021

New insights on fibrodysplasia ossificans progressiva: discussion of an autoptic case report and brief literature review.

Vittorio Bolcato, Claudia Carelli, Silvia Damiana Visonà, Marcella Reguzzoni, Maja Di Rocco, Alessandra Radogna, Livio Pietro Tronconi, Matteo Moretti

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Intractable & rare diseases research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vittorio BolcatoDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Claudia CarelliDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Silvia Damiana VisonàDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Marcella ReguzzoniDepartment of Medicine and Surgery, Insubria University, Varese, Italy.
Maja Di RoccoRare Diseases Unit, Istituto Pediatrico Giannina Gaslini, Genoa, Italy.
Alessandra RadognaDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Livio Pietro TronconiDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Matteo MorettiDepartment of Public Health, Experimental and Forensic Medicine, Forensic Science Section "Antonio Fornari", University of Pavia, Pavia, Italy.
Fondazione Istituto Neurologico Nazionale Casimiro Mondino · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic condition with soft tissue progressive ossification, leading to severe disability. We describe a 27-years-old female affected by FOP who died after a fall. An autopsy was performed. Upper and lower extremities resulted in fixed flexion, with kyphoscoliosis of the spine and chest wall deformity. Moreover, a cranial fracture was pointed out. At histology, atypical abundance of

Indexed as

corpora amylaceafibrodysplasia ossificans progressivafibrosisthyroiditistransmission electron microscopy

Identifiers

PMID33996361
PMCPMC8122314
OpenAlexW3160350177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.